Hi to all board followers.
Management have managed to get rid of the guy who invented the product and several decent staff over the last 12 months and at the same time progress seems to have slowed to snails pace. I know the product is great but the path to commercialisation is being seriously compromised. How many good people have they got left and why to they seem to keep alienating great hires to the point that they leave? And if you believe that they had finished what they were there to do etc - you are very naive. They all left because the were either very dissatisfied or were shifted on.
I am not wanting to be overly negative but I have seen too many instances where shareholders place all their faith in the MD and PR and never consider that they may in fact not be doing such a great job.
And before someone tells me to sell my shares and invest in something else - I am OK holding my remaining shares in the hope that this thing comes right because fundamentally I think we have a good product but I would urge caution around believing that the only way is up. The market is littered with graves of shares which were pumped by MD's and PR people right up until the day they closed the doors and typically it is the people like you and me who get burnt the most.
If the story was really as good as some seem to believe then why do we not see any Directors Interest notices informing us that the MD and other key management had taken the chance to stock up on more shares at these "incredibly low prices". They have windows in which they can buy but quite clearly they choose not to - do you not ask yourself why? How many shares does Dave Rosa hold in this sure thing? As many as you?
I really hope things come right but as we are now, the prospects of things improving quickly are very limited. Instos and large investors will not consider backing SSH until they see some meaningful data - and the "facts" that are posted here from time to time are not meaningful data or the price would not be where it is. They want to see an increase in enrolments and survival stats. They are not going to see an increase in these numbers any time soon. We can already assume that the devices were implanted in pretty sick people (maybe too sick) and that there were a number of "events" as a result. Have they got the implant target right? You have to hope so but if they haven't then there are possibly going to be more events. The enrolment momentum was lost while enrolments were on hold so again you can assume that there has been little progress made since things kicked off again so what do you think they are likely to say when they next get an update out?
I am not saying that SSH is a disaster (and I am not saying it isn't - only time will tell) but I am saying that things are unlikely to turn around any time soon. On the back of that however, cash is only forecast to last until the end of 2016 so capital raising creeps closer and the closer it gets the more cautious large investors (as in large enough to positively influence the share price) will become and the better the news will have to be to trigger an upwards movement in the share price.
At this point in time the smartest investors over the last 12 months have been those who have shorted - so on that basis keep an eye on them. In my experience to date they have been significantly more accurate in their predictions of the short term future of SSH than the people who believe we are on the verge of riches.
DYOR and good luck to all. I still have a reasonable position and hope just like I am sure you do that things take off - but if you need the money that you have invested in SSH, there are better places for it!!
- Forums
- ASX - By Stock
- SHC
- Sunshine Heart Price Target Cut to $12.00 (SSH)
Sunshine Heart Price Target Cut to $12.00 (SSH), page-18
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online